✦ LIBER ✦

Incretin-based drugs and risk of pancreatitis: latest data

Book ID: 125389452
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2014
Weight: 219 KB
Volume: 1500
Category: Article
ISSN: 0114-9954
DOI: 10.1007/s40278-014-0586-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incretin-based drugs: risk of pancreatit

Incretin-based drugs: risk of pancreatitis assessed

📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 199 KB

Pancreatitis and incretin-based drugs: c

Pancreatitis and incretin-based drugs: clarity or confusion?

✍ Nauck, Michael A; Meier, Juris J 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 104 KB

Risk of pancreatitis in patients treated

Risk of pancreatitis in patients treated with incretin-based therapies

✍ Meier, Juris J.; Nauck, Michael A. 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 123 KB

Incretin-Based Drugs and the Risk of Con

Incretin-Based Drugs and the Risk of Congestive Heart Failure

✍ Yu, Oriana Hoi Yun; Filion, Kristian B.; Azoulay, Laurent; Patenaude, Valerie; M 📂 Article 📅 2014 🏛 American Diabetes Association 🌐 English ⚖ 931 KB

FDA and EMA assess the pancreatic safety

FDA and EMA assess the pancreatic safety of incretin-based drugs

📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 199 KB

Extra-pancreatic effects of incretin-bas

Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetes

✍ van Genugten, R. E.; Möller-Goede, D. L.; van Raalte, D. H.; Diamant, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 572 KB